Ocular toxicity of fludarabine: a purine analog

Article Properties
Cite
Ding, Xiaoyan, et al. “Ocular Toxicity of Fludarabine: A Purine Analog”. Expert Review of Ophthalmology, vol. 3, no. 1, 2008, pp. 97-109, https://doi.org/10.1586/17469899.3.1.97.
Ding, X., Herzlich, A. A., Bishop, R., Tuo, J., & Chan, C.-C. (2008). Ocular toxicity of fludarabine: a purine analog. Expert Review of Ophthalmology, 3(1), 97-109. https://doi.org/10.1586/17469899.3.1.97
Ding X, Herzlich AA, Bishop R, Tuo J, Chan CC. Ocular toxicity of fludarabine: a purine analog. Expert Review of Ophthalmology. 2008;3(1):97-109.
Journal Category
Medicine
Ophthalmology
Refrences
Title Journal Journal Categories Citations Publication Date
10.1016/S0140-6736(07)61125-8 2007
A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders Leukemia Research
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
 86 2007
Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pretreated patients with chronic lymphocytic leukemia Leukemia Research
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
 6 2007
10.1200/JCO.2006.08.0762 2007
10.1007/BF02685912 2007
Refrences Analysis
Category Category Repetition
Medicine: Medicine (General)26
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens22
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs12
Medicine: Public aspects of medicine: Toxicology. Poisons7
Medicine: Therapeutics. Pharmacology5
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system4
Medicine: Internal medicine3
Science: Chemistry: Organic chemistry: Biochemistry1
The category Medicine: Medicine (General) 26 is the most frequently represented among the references in this article. It primarily includes studies from Leukemia Research and Cancer Research. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
Efectos secundarios oculares de las terapias oncológicas. Revisión Archivos de la Sociedad Española de Oftalmología 2024
Ocular side effects of oncological therapies: Review Archivos de la Sociedad Española de Oftalmología (English Edition) 2024
Ophthalmic Manifestations in Patients with Blood Malignancies

 Hematology Reports
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
 2024
Antiviral Treatment Options for Severe Fever with Thrombocytopenia Syndrome Infections Infectious Diseases and Therapy
  • Medicine: Internal medicine: Infectious and parasitic diseases
  • Medicine: Internal medicine: Infectious and parasitic diseases
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Internal medicine: Infectious and parasitic diseases
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
 5 2022
Erdheim-Chester disease: a comprehensive review from the ophthalmologic perspective Survey of Ophthalmology
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
 8 2022
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)6
Medicine: Ophthalmology5
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system3
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry3
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy2
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs2
Medicine1
Science1
Science: Science (General)1
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine1
Medicine: Public aspects of medicine: Toxicology. Poisons1
Medicine: Therapeutics. Pharmacology1
Medicine: Internal medicine: Infectious and parasitic diseases1
Medicine: Surgery1
Science: Biology (General)1
Science: Physics1
The category Medicine: Medicine (General) 6 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation and was published in 2010. The most recent citation comes from a 2024 study titled Ophthalmic Manifestations in Patients with Blood Malignancies. This article reached its peak citation in 2010, with 4 citations. It has been cited in 16 different journals, 18% of which are open access. Among related journals, the Hematology Reports cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year